{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:51:31Z","timestamp":1781203891862,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000860","name":"European Society of Cardiology","doi-asserted-by":"publisher","award":["R-2016\u2013013"],"award-info":[{"award-number":["R-2016\u2013013"]}],"id":[{"id":"10.13039\/501100000860","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jaccao.2020.11.008","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T03:28:37Z","timestamp":1608175717000},"page":"735-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impact of Cancer in Patients Undergoing Transcatheter Aortic Valve Replacement"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9122-797X","authenticated-orcid":false,"given":"Alexander","family":"Lind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Totzeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir A.","family":"Mahabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf A.","family":"J\u00e1nosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El Gabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjang","family":"Ruhparwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone M.","family":"Mrotzek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Akdeniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tienush","family":"Rassaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca I.","family":"Mincu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccao.2020.11.008_bib1","first-page":"252","article-title":"Cancer treatment and survivorship statistics, 2014","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaccao.2020.11.008_bib2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(16)32616-2","article-title":"11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial","volume":"389","author":"Cameron","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2020.11.008_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0140-6736(15)01088-0","article-title":"Antiangiogenic therapy in oncology: current status and future directions","volume":"388","author":"Jayson","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2020.11.008_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2019.01.038","article-title":"Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease","volume":"280","author":"Totzeck","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jaccao.2020.11.008_bib5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejso.2016.07.145","article-title":"Immunotherapy in melanoma: Recent advances and future directions","volume":"43","author":"Franklin","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jaccao.2020.11.008_bib6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2020.11.008_bib7","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(17)31821-4","article-title":"Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16\u201326 years: a randomised, double-blind trial","volume":"390","author":"Huh","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2020.11.008_bib8","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2020.11.008_bib9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.amjcard.2016.05.052","article-title":"Comparison of results of transcatheter aortic valve implantation in patients with versus without active cancer","volume":"118","author":"Watanabe","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jaccao.2020.11.008_bib10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.amjcard.2017.06.032","article-title":"Impact of potentially malignant incidental findings by computed tomographic angiography on long-term survival after transcatheter aortic valve implantation","volume":"120","author":"van Kesteren","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jaccao.2020.11.008_bib11","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2020.11.008_bib12","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2020.11.008_bib13","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2020.11.008_bib14","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2020.11.008_bib15","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2020.11.008_bib16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2020.11.008_bib17","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1200\/JCO.2007.10.9777","article-title":"American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects","volume":"25","author":"Carver","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2020.11.008_bib18","first-page":"726","article-title":"Urgent transcatheter aortic valve implantation in patients with severe aortic stenosis and acute heart failure: procedural and 30-day outcomes","volume":"32","author":"Landes","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jaccao.2020.11.008_bib19","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/ejcts\/ezs533","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2)","volume":"42","author":"Kappetein","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jaccao.2020.11.008_bib20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.jaccao.2020.11.008_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1010-7940(99)00134-7","article-title":"European system for cardiac operative risk evaluation (EuroSCORE)","volume":"16","author":"Nashef","year":"1999","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jaccao.2020.11.008_bib22","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1010-7940(99)00106-2","article-title":"Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients","volume":"15","author":"Roques","year":"1999","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jaccao.2020.11.008_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCINTERVENTIONS.108.819839","article-title":"Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system","volume":"1","author":"Grube","year":"2008","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jaccao.2020.11.008_bib24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCULATIONAHA.105.582882","article-title":"Percutaneous aortic valve implantation retrograde from the femoral artery","volume":"113","author":"Webb","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2020.11.008_bib25","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2044.2011.06788.x","article-title":"Transfemoral aortic valve implantation under sedation and monitored anaesthetic care--a feasibility study","volume":"66","author":"Bergmann","year":"2011","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jaccao.2020.11.008_bib26","first-page":"877","article-title":"A\u00a0modified \u201cpreclosure\u201d technique after percutaneous aortic valve replacement","volume":"72","author":"Kahlert","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jaccao.2020.11.008_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaccao.2020.11.008_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jaccao.2020.11.008_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1470-2045(05)70207-2","article-title":"Cancer and venous thromboembolism","volume":"6","author":"Prandoni","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaccao.2020.11.008_bib30","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","article-title":"5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Mack","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2020.11.008_bib31","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2020.11.008_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcin.2018.10.026","article-title":"Transcatheter aortic valve replacement in oncology patients with severe aortic stenosis","volume":"12","author":"Landes","year":"2019","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jaccao.2020.11.008_bib33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/joic.12458","article-title":"Impact of active cancer disease on the outcome of patients undergoing transcatheter aortic valve replacement","volume":"31","author":"Mangner","year":"2018","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.jaccao.2020.11.008_bib34","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu282","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2020.11.008_bib35","doi-asserted-by":"crossref","first-page":"S4386","DOI":"10.21037\/jtd.2018.11.110","article-title":"Modern concepts in cardio-oncology","volume":"10","author":"Rassaf","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jaccao.2020.11.008_bib36","first-page":"856","article-title":"Heart failure from cancer therapy: can we prevent it?","volume":"6","author":"Totzeck","year":"2019","journal-title":"ESC Heart\u00a0Failure"},{"key":"10.1016\/j.jaccao.2020.11.008_bib37","article-title":"Cardiovascular adverse events in patients with cancer treated with bevacizumab: a meta-analysis of more than 20 000 patients","volume":"6","author":"Totzeck","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jaccao.2020.11.008_bib38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/2047487318755193","article-title":"Cardiovascular diseases in patients receiving small molecules with anti-vascular endothelial growth factor activity: A meta-analysis of approximately 29,000 cancer patients","volume":"25","author":"Totzeck","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jaccao.2020.11.008_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.8890","article-title":"Cardiovascular adverse events associated with BRAF and MEK inhibitors: a systematic review and meta-analysis","volume":"2","author":"Mincu","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaccao.2020.11.008_bib40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-115-6-478","article-title":"Withholding and withdrawing life-sustaining therapy","volume":"115","author":"Lanken","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaccao.2020.11.008_bib41","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jcin.2014.01.167","article-title":"Futility, benefit, and transcatheter aortic valve replacement","volume":"7","author":"Lindman","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Intv"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087320302891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087320302891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:53:39Z","timestamp":1762973619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087320302891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2666087320302891"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2020.11.008","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Cancer in Patients Undergoing Transcatheter Aortic Valve Replacement","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2020.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}